
Bioorganic and Medicinal Chemistry p. 731 - 737 (1997)
Update date:2022-08-04
Topics:
Angeli
Brasili
Cingolani
Marucci
Piergentili
Pigini
Quaglia
To develop ligands that may be useful in exploring muscarinic receptor heterogeneity, we synthesized a series of analogues of 2,2-diphenyl-[1,3]-dioxolan-4-ylmethyl-dimethylamine oxalate and methiodide bearing a modified cationic head. These compounds, when tested on tissues containing the three subtypes M1, M2, and M3, behaved as muscarinic antagonists whose results showed that different substituents on the quaternary and tertiary nitrogen affect affinity and selectivity in different ways. In particular, comparison of the affinities of these ligands with those of the reference compounds points out that compounds bearing an ethyl substituent improve the affinity of the molecule at the three subtypes, while compounds bearing a phenethyl substituent are more selective for the M3 sites.
View MoreContact:17316303296
Address:240 Amboy Ave
SHANGHAI T&W PHARMACEUTICAL CO., LTD.
website:http://www.trustwe.com
Contact:+86-21-61551413
Address:601, No. 1, 2277 Nong, Zu Chongzhi Road, Zhangjiang Hightech. Park, Pudong
Anqing World Chemical Co., Ltd.
Contact:+86-556-5800026
Address:Daguan Economic Development Zone of circular economy industrial park Anqing City Anhui province
Jinan Jianfeng Chemical Co., Ltd
Contact:0086-531-88110457
Address:sales01(-a-t-)pharmachemm{dot}c+o+m
Jiangsu Chiatai Qingjiang Pharmaceutical Co.,Ltd
Contact:+86-517-86283327
Address:9 North Hantai Road, Huaian, China
Doi:10.1016/S0040-4039(00)72081-8
(1975)Doi:10.1248/cpb.26.1511
(1978)Doi:10.1002/anie.201809051
(2018)Doi:10.1002/j.2050-0416.2001.tb00089.x
(1937)Doi:10.1021/acsmedchemlett.9b00071
(2019)Doi:10.1039/a701770g
(1997)